Background There is conflicting evidence about whether a double dose of the hepatitis B
virus (HBV) vaccine induces better immunity than the standard-dose vaccine for people …

Hepatitis B virus (HBV) infection is a leading cause of chronic hepatitis, liver cirrhosis, and
hepatocellular carcinoma worldwide. Due to the shared modes of transmission, coinfection …

Hepatitis B and A account for considerable morbidity and mortality worldwide. Immunization
is the most effective means of preventing hepatitis B and A. However, the immune response …

HIV and hepatitis B virus co-infection leads to substantially increased morbidity and mortality
compared with either infection alone. Immunisation with hepatitis B virus vaccine is the most …

In this international, multicenter open-label study (ACTG A5379) of HepB-CpG vaccine in
people with human immunodeficiency virus (HIV) without prior hepatitis B virus (HBV) …

Abstract Background Hepatitis B virus (HBV) and human immunodeficiency virus (HIV)
share transmission mechanisms and thus coinfection is frequent. Active immunization …

ABSTRACT HBV immunization is highly recommended in people infected with HIV.
However, the classical schedule used in the general population has been shown to be …

Among persons living with human immunodeficiency virus (HIV) infection, liver disease
remains a major cause of morbidity and mortality. While the etiologies are varied and often …

Background: Patients with HIV-infection often respond poorly to vaccination. We sought to
determine rates of seroconversion among HIV-infected patients receiving the hepatitis B …

Background With the advent of highly active antiretroviral drugs for the treatment of human
immunodeficiency virus (HIV) it has become possible for people with HIV to travel to …